Kindred Biosciences (KIN)

9.25  +0.01 (+0.11%)

After market: 9.26 +0.01 (+0.11%)

Buy % Consensus

60

ChartMill assigns a Buy % Consensus number of 60% to KIN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 9.69. This target is 4.76% above the current price.
KIN was analyzed by 5 analysts. The buy percentage consensus is at 60. So analysts seem to be rather neutral about KIN.
In the last month the buy percentage fell by 8 points. So the trust of analysts is decreasing.
Only 5 analysts analyzed KIN. So this is just the average opinion of a couple of analysts.

Price Target & Forecast

Price Low Median Mean High 9.259.099.449.6911.55 - -1.73% 2.00% 4.76% 24.86%
Up and Down Grades
Date Firm Action Rating
2021-06-17 Lake Street Downgrade Buy -> Hold
2021-06-17 HC Wainwright & Co. Downgrade Buy -> Neutral
2021-06-16 Aegis Capital Downgrade Buy -> Hold